Specialty Drugs Are Driving Health Insurance Costs: What Employers Need To Know
Forbes • Mon Apr 06 2026
Health insurance has always been expensive. What’s changed is not just the scale of these costs, but their unpredictability and concentration.
Health insurance has always been expensive. What’s changed is not just the scale of these costs, but their unpredictability and concentration. Specialty drugs have become a significant driver of employer health care cost growth, with U.S. employer expenses projected to rise around 10% this year according to an International Foundation of Employee Benefit Plans survey—a pace employers haven’t experienced in more than 15 years. For many organizations, this level of volatility now represents a balance-sheet risk, not just a benefits challenge.
To read more, click here
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.